| scholarly article | Q13442814 |
| P50 | author | Xin Chen | Q61142246 |
| P2093 | author name string | Yuan Lu | |
| Liang Ma | |||
| Qi Zheng | |||
| Weidong Li | |||
| Yiming Ni | |||
| Yufei Fu | |||
| P2860 | cites work | Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC). | Q26775394 |
| Therapeutic options targeting angiogenesis in nonsmall cell lung cancer | Q26823727 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Progression and metastasis of lung cancer | Q28066865 | ||
| Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice | Q28586727 | ||
| The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6 | Q28593218 | ||
| STATs and Gene Regulation | Q29547796 | ||
| Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients | Q33269548 | ||
| DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer | Q33403305 | ||
| The role of STATs in transcriptional control and their impact on cellular function | Q33941346 | ||
| Mechanical signals control SOX-9, VEGF, and c-Myc expression and cell proliferation during inflammation via integrin-linked kinase, B-Raf, and ERK1/2-dependent signaling in articular chondrocytes | Q34027557 | ||
| Janus kinases: components of multiple signaling pathways | Q34103659 | ||
| Angiogenesis and lung cancer: prognostic and therapeutic implications | Q34417759 | ||
| SOX18 and the Transcriptional Regulation of Blood Vessel Development | Q34453487 | ||
| Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer | Q36242082 | ||
| Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. | Q36345226 | ||
| SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition | Q52655063 | ||
| SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma | Q53641986 | ||
| Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC. | Q53753820 | ||
| MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5 | Q85753535 | ||
| Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice | Q36497233 | ||
| MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling | Q37694851 | ||
| Markers of response for the antiangiogenic agent bevacizumab | Q38080828 | ||
| Sox7 in vascular development: review, insights and potential mechanisms | Q38214795 | ||
| Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression | Q38295227 | ||
| Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor | Q38498207 | ||
| SOX-mediated molecular crosstalk during the progression of tumorigenesis. | Q38836028 | ||
| Cancer treatment and survivorship statistics, 2016. | Q38859236 | ||
| Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1. | Q39017400 | ||
| JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer | Q39589684 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor | Q40577694 | ||
| Strategies targeting angiogenesis in advanced non-small cell lung cancer | Q41593429 | ||
| Dimerization as a regulatory mechanism in signal transduction | Q46409691 | ||
| Cantharidin inhibits angiogenesis by suppressing VEGF-induced JAK1/STAT3, ERK and AKT signaling pathways | Q46439972 | ||
| Sox18 and Sox7 play redundant roles in vascular development | Q47073479 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| SoxF Transcription Factors Are Positive Feedback Regulators of VEGF Signaling | Q48568785 | ||
| Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. | Q49239882 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| angiogenesis | Q539568 | ||
| P304 | page(s) | 5733-5741 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | SOX5 induces lung adenocarcinoma angiogenesis by inducing the expression of VEGF through STAT3 signaling | |
| P478 | volume | 11 |
Search more.